Vericel (NASDAQ:VCEL) Receives “Buy” Rating from HC Wainwright
HC Wainwright restated their buy rating on shares of Vericel (NASDAQ:VCEL – Free Report) in a report issued on Friday,Benzinga reports. HC Wainwright currently has a $60.00 price objective on the biotechnology company’s stock. HC Wainwright also issued estimates for Vericel’s FY2025 earnings at $0.26 EPS, FY2027 earnings at $1.18 EPS, FY2028 earnings at $1.93 […]
